BIOTIME Net Income From Continuing Ops from 2010 to 2026
| BT3 Stock | EUR 1.35 0.00 0.00% |
Net Loss | First Reported 2019-03-31 | Previous Quarter -30.4 M | Current Value -29.8 M | Quarterly Volatility 13.1 M |
Check BIOTIME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIOTIME's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 2.1 M or Interest Expense of 0.0, as well as many indicators such as . BIOTIME financial statements analysis is a perfect complement when working with BIOTIME Valuation or Volatility modules.
BIOTIME | Net Income From Continuing Ops |
Analyzing BIOTIME's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing BIOTIME's current valuation and future prospects.
Latest BIOTIME's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of BIOTIME over the last few years. It is BIOTIME's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BIOTIME's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
BIOTIME Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (6,835,635) | |
| Geometric Mean | 20,898,005 | |
| Coefficient Of Variation | (344.90) | |
| Mean Deviation | 20,964,287 | |
| Median | (16,723,800) | |
| Standard Deviation | 23,575,900 | |
| Sample Variance | 555.8T | |
| Range | 65.4M | |
| R-Value | (0.73) | |
| Mean Square Error | 275.7T | |
| R-Squared | 0.54 | |
| Significance | 0.0008 | |
| Slope | (3,414,947) | |
| Total Sum of Squares | 8893.2T |
BIOTIME Net Income From Continuing Ops History
About BIOTIME Financial Statements
BIOTIME stakeholders use historical fundamental indicators, such as BIOTIME's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although BIOTIME investors may analyze each financial statement separately, they are all interrelated. For example, changes in BIOTIME's assets and liabilities are reflected in the revenues and expenses on BIOTIME's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BIOTIME. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -16.7 M | -17.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BIOTIME Stock
BIOTIME financial ratios help investors to determine whether BIOTIME Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOTIME with respect to the benefits of owning BIOTIME security.